Nikkei Biotech Inc. published the article on its website
Nikkei Biotech Inc. published the article titled "Culgen Inc. (U.S.) developing six targeted protein degrader oncology compounds - An Interview with key Executives visiting Japan "
on its website as of August 30, 2019.
Please see below link for further details. Nikkei Web (for paying subscribers, Japanese only):